PHARMING GROUP N.V.

PHARM
Real-time Quote. Real-time  - 09/24 11:35:03 am
0.831EUR -1.07%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Sales per Business
20192020
Recombinant Human C1 Esterase Inhibitor169.02100%185.69100%
EUR in Million
Sales per region
20192020
United States162.6996.3%177.3995.5%
Europe5.043%7.213.9%
Rest of the World1.290.8%1.100.6%
EUR in Million
Managers
Name Title
Sijmen de Vries Chief Executive Officer & Executive Director
Jeroen Henk Wakkerman Chief Financial Officer
Paul Jai Sekhri Chairman
Anurag Relan Chief Medical Officer
Robert Friesen Chief Scientific Officer
Mireille Sanders Senior Vice President-Operations
Ruud van Outersterp Chief Ethics & Compliance Officer
Deborah A. Jorn Vice Chairman
Barbara Yanni Non-Executive Director
Mark Jerome Pykett Non-Executive Director
Shareholders
Name Equities %
Goldman Sachs Asset Management LP 13,674,620 2.14%
BlackRock Fund Advisors 10,309,066 1.62%
Schroder Investment Management Ltd. 9,582,137 1.50%
Schroder Investment Management North America, Inc. 9,005,064 1.41%
Healthinvest Partners AB 8,700,000 1.36%
Sijmen de Vries 7,095,927 1.11%
LSV Asset Management 4,190,800 0.66%
DWS Investments (UK) Ltd. 3,887,739 0.61%
Teachers Advisors LLC 3,390,728 0.53%
Nordea Investment Management AB 3,027,744 0.47%
Company contact information
Darwinweg 24
POBox 451
NL-2333 CR Leiden, Zuid-Holland


Phone : +31 (0)71 52 47 400
Fax : +31 (0)71 52 47 445
web site : http://www.pharming.com
Markets and indexes
- Compartiment B
- AScX / Next 150, PEA, Tech 40
Stock Exchange Codes
- Bloomberg Code :  PHARM:NA
- Reuters Code :  PHAR.AS
- Datastream Code :  H:PHAG
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PHARMING GROUP N.V.-34.85%637
JOHNSON & JOHNSON4.75%433 991
ROCHE HOLDING AG10.87%324 441
PFIZER, INC.19.40%247 760
NOVO NORDISK A/S51.58%233 750
ELI LILLY AND COMPANY37.51%210 490
ABBVIE INC.0.20%189 724
NOVARTIS AG-7.58%187 151
MERCK & CO., INC.-10.70%184 917
ASTRAZENECA PLC18.35%184 418
BRISTOL-MYERS SQUIBB COMPANY-2.26%134 727
AMGEN INC.-6.47%122 117
SANOFI5.29%122 060
GLAXOSMITHKLINE PLC5.37%97 195
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-24.86%61 711
DAIICHI SANKYO COMPANY, LIMITED-12.76%53 646
BAYER AG-3.42%53 623
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.40%53 383
JIANGSU HENGRUI MEDICINE CO., LTD.-48.55%47 150
ASTELLAS PHARMA INC.16.91%31 344
Brand Portfolio
» More brands of Pharming Group N.V.